日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chronic In Vivo Biostability and Biocompatibility Evaluation of Polyether-Urethane-Based Balloon Implants for Cardiac Application in a Porcine Model

在猪模型中对用于心脏手术的聚醚-聚氨酯基球囊植入物进行慢性体内生物稳定性和生物相容性评价

Kim, Min-Gi; Seo, Jae-Young; Kim, June-Hong; Kim, Jin-Chang; Park, Jun-Yong; Song, Hyun-A; Song, Kyeong-Deok; Chon, Min-Ku

Sequential nanoparticle therapy targeting neutrophil hyperactivation to prevent neutrophil-induced pulmonary fibrosis.

针对中性粒细胞过度活化的序贯纳米颗粒疗法,可预防中性粒细胞诱导的肺纤维化

Lee Hye-Jin, Lee Na Kyeong, Kim Jisun, Kim Jungbum, Seo Donghyuk, Shin Ha Eun, Kim Jongsu, Ahn June Hong, Kim Se-Na, Kim Hong Sook, Park Juwon, Park Wooram, Hong Kyung Soo, Park Chun Gwon, Lee Wonhwa

Engineering an immune-integrated lung-on-a-chip to reveal TOX-RAGE axis-driven fibrosis and RAGE blockade as a therapeutic strategy.

构建免疫整合的芯片肺,以揭示 TOX-RAGE 轴驱动的纤维化,并将 RAGE 阻断作为治疗策略。

Kim Hyelim, Park Chai Won, Kim Jisun, Kim Seong-Eun, Ahn June Hong, Seong Je Kyung, Lee Wonhwa, Cho Seung-Woo, Kim Hong Nam

Low levels of serum albumin and blood basophils as 10-year mortality predictors in a nationwide Korean COPD cohort

韩国全国慢性阻塞性肺病队列研究中,血清白蛋白和嗜碱性粒细胞水平低可作为10年死亡率的预测指标

Park, Hye Jung; Song, Yeseul; Kim, Youlim; Ahn, June Hong; Lee, Chang Youl; Kim, Deog Kyeom; Moon, Ji-Yong; Lee, Won-Yeon; Yoo, Kwang Ha; Byun, Min Kwang

Factors predicting early recurrence in patients with unresectable stage III non-small cell lung cancer on durvalumab consolidation after chemoradiotherapy

预测接受度伐利尤单抗巩固治疗的不可切除的III期非小细胞肺癌患者在放化疗后早期复发的因素

Park, Ji Eun; Kim, Chanmi; Choi, Sun Ha; Jang, Jong Geol; Hong, Kyung Soo; Kwon, Yong Shik; Choi, Keum-Ju; Eom, Jung Seop; Kim, Saerom; Seol, Hee Yun; Kim, Jehun; Kim, Insu; Park, Jin Han; Kim, Tae Hoon; Ahn, June Hong

Pathologic complete response following salvage surgery after lazertinib treatment in advanced EGFR-mutated lung adenocarcinoma: case report and literature review

晚期EGFR突变肺腺癌经拉泽替尼治疗后挽救性手术达到病理完全缓解:病例报告及文献复习

Kim, Chanmi; Park, Jongsoo; Lee, Jang Hoon; Jeong, Seong Yong; Ahn, June Hong

Adjuvant chemotherapy before osimertinib in EGFR-mutated stage IB lung adenocarcinoma: a clinical dilemma

EGFR突变型IB期肺腺癌患者在接受奥希替尼治疗前进行辅助化疗:一个临床难题

Park, Sun Hyo; Park, Jin Han; Kim, Tae Hun; Choi, Sun Ha; Park, Ji Eun; Kim, Insu; Kim, Ji Yeon; Kim, Tae Hoon; Lee, Taehoon; Cho, Hyun Kyu; Jeong, Jong Hwan; Yang, Jung Wook; Lee, Hyun-Kyung; Lee, Ho Young; Jung, Ho Jin; Eom, Jung Seop; Ahn, June Hong

Chronic obstructive pulmonary disease is a risk factor for non-tuberculous mycobacterial pulmonary disease: a population-based matched cohort study

慢性阻塞性肺疾病是非结核分枝杆菌肺病的一个危险因素:一项基于人群的匹配队列研究

Jang, Jong Geol; Lee, Hyun; Kang, Min Gu; Kim, Youlim; Yoo, Kwang Ha; Min, Kyung Hoon; Ahn, June Hong; Hong, Kyung Soo; Kim, Jong Seung; Moon, Ji-Yong

Efficacy and safety of first-line afatinib in older patients with advanced EGFR-mutated non-small cell lung cancer

阿法替尼一线治疗老年晚期EGFR突变型非小细胞肺癌患者的疗效和安全性

Kim, Mi-Hyun; Seong, Hayoung; Kim, Soo Han; Lee, Min Ki; Kim, Insu; Hong, Kyung Soo; Ahn, June Hong; Eom, Jung Seop

Impact of Modifying Lazertinib Doses on Effectiveness and Safety in Patients With EGFR-Positive Advanced Lung Cancer: A Multicenter, Prospective Observational Cohort Study

调整拉泽替尼剂量对EGFR阳性晚期肺癌患者疗效和安全性的影响:一项多中心前瞻性观察队列研究

Kim, Mi-Hyun; Lee, Min Ki; Park, Ji Eun; Park, Sun Hyo; Jang, Tae Won; Jung, Chi Young; Kim, Insu; Yoon, Seong Hoon; Ahn, June Hong; Lee, Hyun-Kyung; Park, Jin Han; Choi, Sun Ha; Eom, Jung Seop